Recall
FDAHealthFebruary 28, 2025

Glenmark Pharmaceuticals Inc., USA — Carvedilol Tablets USP 25 mg, 500 -Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahw

⚠️ CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
February 28, 2025

U.S. Nationwide

What's affected?

Product
Carvedilol Tablets USP 25 mg, 500 -Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC 68462-165-05.
UPC
0368462162019
Lot code
19231107

Additional details

Lot, expiry: Lots 19231107, 19231114, 19231152, Exp Feb-25; Lot 19234866, Exp Jan-26

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 18,696 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.